News and Activities
Hot Off The Press.
Press Releases
StrataDx & Proteocyte AI Announce Partnership Agreement serving U.S. markets
Toronto, ON; December 13, 2024 – Proteocyte AI—an innovative company that develops and commercializes individualized tests to predict risk of developing cancer, and StrataDx—a clinical and anatomic pathology diagnostic laboratory, announce a new strategic partnership agreement for the U.S. market....
Proteocyte Expands Globally with Distribution Agreement in Turkey
Toronto, ON; December 12, 2024 – Proteocyte Diagnostics announces its partnership with Pharmackt (www.pharmackt.com) to introduce their Oral Cancer Stratification Test, Straticyte, in Turkey for the first time. Pharmackt represents numerous pioneering Molecular Diagnostic companies in the field of...
United Healthcare Now Reimbursing Straticyte™ Test
Patients now have access to a ground-breaking Advanced Diagnostic Laboratory cancer predictive Test for patients at risk of oral cancer. Dallas, TX; October 28, 2024 – Proteocyte announced today that United Healthcare (UHC) is providing coverage for Straticyte™ for National, Regional, and Employer...
Proteocyte Announces Lawrence Murphy as Strategic Advisor Business Development
Toronto, ON; August 5, 2024 – Proteocyte is pleased to announce the appointment of Lawrence Murphy to the role of Strategic Advisor Business Development for both the U.S. and International markets, effective August 1, 2024. As a Senior Executive in the Laboratory Developed Test (LDT) space for...